Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,468 | -127,847 | -100,697 | -89,122 | -78,715 |
| Depreciation Amortization | -1,080 | -6,996 | -5,137 | -76 | 2,246 |
| Other Working Capital | -5,459 | 1,968 | 4,898 | -445 | 4,073 |
| Other Operating Activity | 25,037 | 20,213 | 15,248 | 14,500 | 12,855 |
| Operating Cash Flow | $-110,970 | $-112,662 | $-85,688 | $-75,143 | $-59,541 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -147,319 | 23,325 | -42,554 | -107,170 | 159,374 |
| PPE Investments | -712 | -1,188 | -849 | -2,078 | -939 |
| Investing Cash Flow | $-148,031 | $22,137 | $-43,403 | $-109,248 | $158,435 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 247,661 | 126,715 | 85,885 | 25,624 | 50,986 |
| Other Financing Activity | -2,397 | -168 | -227 | -399 | -1,852 |
| Financing Cash Flow | $245,264 | $126,547 | $85,658 | $25,225 | $49,134 |
| Beginning Cash Position | 59,897 | 23,875 | 67,308 | 226,474 | 78,446 |
| End Cash Position | 46,160 | 59,897 | 23,875 | 67,308 | 226,474 |
| Net Cash Flow | $-13,737 | $36,022 | $-43,433 | $-159,166 | $148,028 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110,970 | -112,662 | -85,688 | -75,143 | -59,541 |
| Capital Expenditure | -712 | -1,188 | -849 | -2,078 | -939 |
| Free Cash Flow | -111,682 | -113,850 | -86,537 | -77,221 | -60,480 |